Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06529835 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

Study acronym: NeuroSpan-1
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 6 to 8v6
  2. Site details revised at 1 of 6 sitesv5
  3. Study sites: 5 to 6v4
  4. Primary completion date: Aug 2027 to Dec 2027v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Aug 2026 to Aug 2027
    • Start date changed from estimate of Sep 2024 to Mar 21, 2025
    • Study sites: 0 to 5
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.
Trial Details
NCT Number NCT06529835
Lead Sponsor Auxilium Biotechnologies
Collaborators: MCRA
Conditions
(from sponsor)		 Peripheral Nerve Injuries
Related terms Peripheral Nerve Injuries
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov